• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Myriad Genetics

Myriad Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Companion Diagnostics: A Strategic Review from an IP Perspective - Patent Eligibility Issues, Recent Developments, and Review of Patenting Activity - Research and Markets

    Companion Diagnostics: A Strategic Review from an IP Perspective - Patent Eligibility Issues, Recent Developments, and Review of Patenting Activity - Research and Markets

  2. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

  3. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.